July 2025 in “International Journal of Trichology” This study reported that six out of seven pediatric patients with refractory patchy alopecia areata experienced significant hair regrowth after one month of oral tofacitinib treatment, suggesting it may be an effective and safe option, although larger studies are needed to evaluate long-term safety.
June 2025 in “International Journal of Ayurveda and Pharma Research” In this case study, a 20-year-old male with alopecia areata experienced complete hair regrowth and symptom relief without recurrence after Ayurvedic Shodhana and Shamana therapy, suggesting Ayurvedic treatments may offer a comprehensive approach to managing this condition.
June 2025 in “Medical alphabet” This review discusses the pathogenesis of alopecia areata and the use of systemic JAK inhibitors in treating severe cases in pediatric patients, highlighting the safety of selective agents for children.
April 2025 in “International Journal of Clinical & Medical Case Studies” This source explains that unlike genetic hormonal alopecia, alopecia areata is associated with inflammatory factors and may also involve psychological and genetic contributions.
April 2025 in “Journal of Applied Cosmetology” This study found that a combination of microneedling with growth factors and low-level light therapy led to visible hair regrowth without side effects in a patient with trichotillomania.
March 2025 in “Medical Science Journal for Advance Research” This study assessed miR-155 levels in the blood of patients with alopecia areata and found significantly different levels compared to healthy controls, indicating that miR-155 may play a significant role in the disease's pathogenesis.
This article discusses the characteristics of alopecia areata but reports no new research results.
March 2025 in “International Journal of Trichology” This study describes a 62-year-old male with trichodaganomania, an urge to bite his mustache hair, who was treated with counseling and placebo medication, highlighting the need for a comprehensive treatment approach including potential psychological and psychiatric interventions if symptoms recur.
January 2025 in “Indian Dermatology Online Journal” This case study highlights the importance of a multidisciplinary approach in diagnosing and managing Vogt-Koyanagi-Harada syndrome, particularly emphasizing the role dermatologists can play in identifying early signs such as hair loss.
January 2025 in “Journal of Dermatology & Dermatologic Surgery” This study reports a unique case of identical twins experiencing alopecia areata at the same time, suggesting potential environmental triggers for this polygenic autoimmune condition.
January 2025 in “Trepo - Institutional Repository of Tampere University” Alopecia areata significantly harms women's self-image, causing reduced confidence and social isolation.
January 2025 in “Sanjeevani Darshan National Journal of Ayurveda & Yoga” This source examines alopecia areata, an autoimmune condition causing patchy hair loss, describing the current reliance on corticosteroid injections despite their severe side effects, and explores Ayurvedic treatments identified as Shaman and Shodhan for managing an equivalent condition called Indralupta.
Understanding both skin and mental health aspects of alopecia areata is crucial for better patient care.
November 2024 in “Dermatology Online Journal” Dupilumab may help treat alopecia areata, but more research is needed.
In this study, researchers examined Baricitinib's role as a treatment for Alopecia Areata, contrasting it with conventional therapies, and found that while effective, Baricitinib may cause adverse reactions depending on individual patient health histories.
August 2024 in “PLoS ONE” This study reported that rosemary is widely used among Jordanians for various purposes, such as improving hair condition and addressing gastrointestinal issues, with younger participants showing higher knowledge about its benefits and uses.
August 2024 in “International Journal of Pharmaceutics” This study found that a specially designed water-in-oil microemulsion containing Panax notoginseng saponins improved hair density and other hair health indicators in mice with telogen effluvium and androgenetic alopecia, offering a promising multi-mechanism strategy for alopecia treatment with potentially fewer side effects than traditional methods.
August 2024 in “Journal of Marine Medical Society” This case report highlighted the use of dermoscopy not only for diagnosing skin disorders but also as an educational tool to inform patients about the harmful effects of unqualified medical advice, particularly highlighting the quackery issue in dermatology.
July 2024 in “South Asian Research Journal of Medical Sciences” In this review, the article explores the role of homeopathy, as supported by the AYUSH ministry, in addressing Alopecia Areata, discussing its global and national prevalence, existing challenges, and recommending a treatment protocol for future programmatic integration.
June 2024 in “Military medicine” This review explored treatment options for alopecia areata in the military health care system, evaluating the pathogenesis and impact of the condition as well as the efficacy and safety of FDA-approved JAK inhibitors, baricitinib and ritlecitinib.
This study suggests that a herbal shampoo made from plant ingredients may be a promising natural remedy for hair fall and dandruff, demonstrating good quality and safety.
April 2024 in “Medical & clinical research” This study reviews the range of both conventional and unconventional treatments for Alopecia Areata, highlighting the promise of biological therapies like JAK inhibitors, but notes more research is needed to optimize treatment effectiveness and personalization.
April 2024 in “International Journal of Research Publication and Reviews” This source highlights that alopecia areata is a complex autoimmune disorder leading to patchy, nonscarring hair loss with variable treatment responses, reflecting unmet clinical needs. Advances in genetic research are improving understanding, yet current treatments often lead to persistent relapses.
In this case report, off-label onabotulinumtoxin-A was successfully used to treat trichodynia, a painful scalp sensation associated with hair loss, in a patient unresponsive to conventional therapies.
March 2024 in “Dermatology and therapy” This study analyzed data from 2083 patients with alopecia areata in Europe and found that those with atopic, autoimmune, or psychiatric comorbidities encountered more severe disease and were more likely to require advanced treatments compared to those without comorbid conditions.
March 2024 in “International Seven Journal of Health Research” In this study, the authors synthesized recent literature on childhood alopecia areata, highlighting its clinical manifestations and management strategies, which include individualized treatments and psychosocial support to mitigate emotional and social impacts on affected children.
February 2024 in “The Open dermatology journal” This systematic review reported that alopecia areata significantly impacts quality of life due to its psychological burdens, such as anxiety and depression, while emphasizing the need for increased awareness and support for affected individuals.
January 2024 in “Journal of Scleroderma and Related Disorders” This study concluded that autologous platelet-rich plasma is a safe and effective technique for improving aesthetic concerns such as contour defects, pigmentation issues, and indurated lesions.
January 2024 in “Sanjeevani Darshan National Journal of Ayurveda & Yoga” This study aims to evaluate the efficacy of a treatment approach called Sthanika Chikitsa, involving Shiro Lepa and specific herbal and nasal preparations, for managing Indralupta, a condition akin to Alopecia Areata characterized by hair loss. Results are not provided in the abstract.
This article reviews the characteristics of alopecia areata, highlights the psychological factors involved, and discusses South American contributions to understanding the disease, but reports no new clinical results.